Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 120 citing articles:

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 513
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancer
Song Li, Wenbin Yu, Fei Xie, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 134
Association of PD-L1 Expression and Other Variables With Benefit From Immune Checkpoint Inhibition in Advanced Gastroesophageal Cancer
Harry H. Yoon, Zhaohui Jin, Oudom Kour, et al.
JAMA Oncology (2022) Vol. 8, Iss. 10, pp. 1456-1456
Open Access | Times Cited: 111
Single-cell landscape reveals active cell subtypes and their interaction in the tumor microenvironment of gastric cancer
Yumin Li, Xueda Hu, Ruichai Lin, et al.
Theranostics (2022) Vol. 12, Iss. 8, pp. 3818-3833
Open Access | Times Cited: 92
Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology
Zhe Wang, Yang Liu, Xing Niu
Seminars in Cancer Biology (2023) Vol. 93, pp. 83-96
Closed Access | Times Cited: 42
Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development
Tadahito Yasuda, Yanru Wang
Trends in cancer (2024) Vol. 10, Iss. 7, pp. 627-642
Open Access | Times Cited: 25
Disitamab vedotin (RC48) plus toripalimab for HER2-expressing advanced gastric or gastroesophageal junction and other solid tumours: a multicentre, open label, dose escalation and expansion phase 1 trial
Yakun Wang, Jifang Gong, Airong Wang, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102415-102415
Open Access | Times Cited: 24
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
Minae An, Arnav Mehta, Byung‐Hoon Min, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 766-785
Open Access | Times Cited: 17
Advances in molecular biomarkers research and clinical application progress for gastric cancer immunotherapy
Hongzhen Cai, Man Li, Ruiyi Deng, et al.
Biomarker Research (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 39
Recent Progress in Immunotherapy for Gastric Cancer
Jeesun Yoon, Tae‐Yong Kim, Do‐Youn Oh
Journal of the Korean Gastric Cancer Association (2023) Vol. 23, Iss. 1, pp. 207-207
Open Access | Times Cited: 28
Baicalin enhances the chemotherapy sensitivity of oxaliplatin-resistant gastric cancer cells by activating p53-mediated ferroptosis
Lihua Shao, Li Zhu, Rong Su, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 14
Applications of single‑cell omics and spatial transcriptomics technologies in gastric cancer (Review)
Liping Ren, Danni Huang, Hongjiang Liu, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 8
Siglec9 + tumor-associated macrophages predict prognosis and therapeutic vulnerability in patients with colon cancer
Chang Jiang, Qingyang Feng, Yihao Mao, et al.
International Immunopharmacology (2024) Vol. 130, pp. 111771-111771
Open Access | Times Cited: 8
Integrative analysis of bulk and single-cell sequencing reveals TNFSF9 as a potential regulator in microsatellite instability stomach adenocarcinoma
Jianlong Zhou, Yucheng Zhang, Yongfeng Liu, et al.
European journal of medical research (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 1
The role of macrophages-mediated communications among cell compositions of tumor microenvironment in cancer progression
Mengyuan Li, Ping Jiang, Shuhua Wei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 21
Tumor Metabolism-Rewriting Nanomedicines for Cancer Immunotherapy
Xiao Dong, Xia Shu, Shubo Du, et al.
ACS Central Science (2023) Vol. 9, Iss. 10, pp. 1864-1893
Open Access | Times Cited: 20
Multiplex immune profiling reveals the role of serum immune proteomics in predicting response to preoperative chemotherapy of gastric cancer
Zhaoqing Tang, Yuan Gu, Zhongyi Shi, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 2, pp. 100931-100931
Open Access | Times Cited: 17
Efficient tumor synergistic chemoimmunotherapy by self-augmented ROS-responsive immunomodulatory polymeric nanodrug
Jinxiao Song, Mingyang Cheng, Yi Xie, et al.
Journal of Nanobiotechnology (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 17
Relationships of tumor differentiation and immune infiltration in gastric cancers revealed by single-cell RNA-seq analyses
Xin Zhou, Jingwei Yang, Yongqu Lu, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 2
Open Access | Times Cited: 16
Current trends in sensitizing immune checkpoint inhibitors for cancer treatment
Jing Wei, Wenke Li, Pengfei Zhang, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 6
Neoadjuvant PD-1 blockade plus chemotherapy induces a high pathological complete response rate and anti-tumor immune subsets in clinical stage III gastric cancer
Xiaohuan Tang, Mengyuan Li, Xiaolong Wu, et al.
OncoImmunology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 26
PD-L1: Biological mechanism, function, and immunotherapy in gastric cancer
Yingzi Zhang, Yan Yang, Yiran Chen, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 23
Single-cell transcriptome sequencing reveals heterogeneity of gastric cancer: progress and prospects
Gaohua Deng, Xu Zhang, Yonglan Chen, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 13
Determinants of Survival with Combined HER2 and PD-1 Blockade in Metastatic Esophagogastric Cancer
Steven B. Maron, Walid K. Chatila, Henry Walch, et al.
Clinical Cancer Research (2023) Vol. 29, Iss. 18, pp. 3633-3640
Open Access | Times Cited: 13
High-temperature PTT/CDT coordination nanoplatform realizing exacerbated hypoxia for enhancing hypoxia-activated chemotherapy to overcome tumor drug resistance
Peng Chang, Yingying Guo, Dan Chen, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top